The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
FGFR gene amplification and response to endocrine therapy in metastatic hormone receptor positive (HR+) breast cancer.
 
Joshua Z. Drago
Stock and Other Ownership Interests - Insulet Corporation (I)
Consulting or Advisory Role - Aetna (I)
 
Andrzej Niemierko
No Relationships to Disclose
 
Laura Spring
No Relationships to Disclose
 
Beverly Moy
Consulting or Advisory Role - MOTUS (I)
 
Dejan Juric
Consulting or Advisory Role - Eisai; EMD Serono; Novartis
 
Steven J. Isakoff
Consulting or Advisory Role - Abbvie; Merrimack; Myriad Genetics; PharmaMar
Research Funding - Abbvie; Genentech; OncoPep; PharmaMar
Travel, Accommodations, Expenses - Myriad Genetics
 
A. John Iafrate
Stock and Other Ownership Interests - Archer
Consulting or Advisory Role - Chugai Pharma; Constellation Pharmaceuticals; Debiopharm Group
Research Funding - Blueprint Medicines
Patents, Royalties, Other Intellectual Property - ArcherDx exclusive license to AMP technology
 
Leif W. Ellisen
Honoraria - Invitae
Consulting or Advisory Role - Vertex
Travel, Accommodations, Expenses - Invitae
 
Aditya Bardia
Consulting or Advisory Role - Genentech; Novartis